While these exciting findings are consistent with the paradigm that metabolic reprogramming promotes cancer [264], more studies are needed to test and verify the importance of metabolic gene control by p53 (as well as other non-traditional targets) to tumor suppression. Here, TP53 is linked to neoplasm.